- Dec 9, 2021
- 1 min read

Overview of COVID-19 Lung Damage Clinical Trial

June 16th, 2020

SDARTs faculty member, Robert W. Alexander, MD, DDS, is the Principle Investigator on a first-in-human clinical trial to treat post-COVID 19 survivors with AD cSVF.

Many moderate to severe post-COVID 19 survivors experience compromised lung function. As a proposed solution, adipose-derived cellular stromal vascular fraction (AD cSVF) may be effective in reversing residual damage to the lungs and gas exchange functions.

This article was published in Stem Cell Research.

Overview_COVID-19_Lung_Damage_cSVF_Final_6-10-20_Stem_Cell_Res

.pdf

Download PDF • 500KB

Want to learn more from Dr. Alexander?

Visit the SDARTs Online Learning Center >

Recent Posts

See All

Effect of Nano Fat Graft on the Healing of Donor Site of SplitThickness Skin Graft

Earlier this month, Dr. Khaled M. Elsherbeny et al. published a study titled "Effect of Nano Fat Graft on the Healing of Donor Site of Split Thickness Skin Graft" in the Egypt Journal of Plastic Recon

Autologous nanofat transplantation accelerates foot wound healing in diabetic rats

In February 2019, Li Chen et al. published their study "Autologous nanofat transplantation accelerates foot wound healing in diabetic rats" Their study "explored the effects of local transplantation o

Use of platelet-rich plasma and modified nanofatgrafting in infected ulcers

This study was published by Francesco Segreto et. al in the Archives of Plastic Surgery. " The aim of this study was to describe the authors’ technique for improving the regenerative and antimicrobial

Overview of COVID-19 Lung Damage Clinical Trial

Recent Posts

STAY IN THE KNOW

Conference Cancellation Policy